Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
US Army
Boehringer Ingelheim
US Department of Justice
Fish and Richardson
Mallinckrodt
McKinsey
Baxter
Cipla

Generated: April 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 076842

« Back to Dashboard

NDA 076842 describes HYDROCORTISONE BUTYRATE, which is a drug marketed by Actavis Mid Atlantic, Glenmark Generics, Taro Pharm Inds, Teligent Pharma Inc, and Taro, and is included in six NDAs. It is available from four suppliers. Additional details are available on the HYDROCORTISONE BUTYRATE profile page.

The generic ingredient in HYDROCORTISONE BUTYRATE is hydrocortisone butyrate. There are sixty-four drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the hydrocortisone butyrate profile page.
Summary for 076842
Tradename:HYDROCORTISONE BUTYRATE
Applicant:Taro
Ingredient:hydrocortisone butyrate
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Formulation / Manufacturing:see details
Pharmacology for NDA: 076842
Suppliers and Packaging for NDA: 076842
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
HYDROCORTISONE BUTYRATE hydrocortisone butyrate OINTMENT;TOPICAL 076842 ANDA Taro Pharmaceuticals U.S.A., Inc. 51672-4083 N 51672-4083-5
HYDROCORTISONE BUTYRATE hydrocortisone butyrate OINTMENT;TOPICAL 076842 ANDA Taro Pharmaceuticals U.S.A., Inc. 51672-4083 N 51672-4083-7

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:OINTMENT;TOPICALStrength0.1%
Approval Date:Dec 27, 2004TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Medtronic
Healthtrust
Cipla
Mallinckrodt
Dow
Farmers Insurance
Deloitte
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.